Business

Latest Business News

📅December 25, 2025 at 1:00 AM
Global markets mixed amid holiday trading with Wall Street records, gold surging to $4,500+, key deals like Sanofi-Dynavax, and strong US GDP growth despite fading confidence.
1

Wall Street Hits Record Highs in Holiday-Thinned Trading

The S&P 500 rose 0.3% to 6,932.05, Dow added 0.6% to 48,731.16, and Nasdaq gained 0.2% to 23,613.31 on light volume ahead of Christmas closure.Source 1Source 4 Tech stocks led gains, buoyed by AI optimism and Trump deregulatory policies, with Nvidia and Micron as top performers.Source 4 Trading volume was about a third of average as markets closed early.Source 4

2

Global Markets Mixed on Year-End Caution

World shares were mixed with Asia's Nikkei down 0.1%, Kospi off 0.2%, Hang Seng up 0.2%, and Shanghai up 0.5%; Europe saw FTSE down 0.2%, CAC up 0.1%.Source 1Source 3 Investors weighed Santa Claus rally against slowdown signs, with many exchanges closing early for Christmas Eve.Source 1 Australia's S&P/ASX 200 slipped 0.4%, India's Sensex fell 0.1%.Source 1Source 3

3

Gold Surges Past $4,500 on Geopolitical Tensions

Gold rose 0.3% to $4,525.20 per ounce, up 70% for the year, while silver climbed 1.6%, driven by safe-haven demand amid US-Venezuela and other risks.Source 1Source 2 Prices hit fresh records after earlier highs this week.Source 3Source 5 Heightened tensions boosted commodities rally.Source 1

4

US Economy Grows at Fastest Pace in Two Years

Q3 GDP expanded at 4.3% annual rate, beating expectations, following 3.8% in Q2; White House credits Trump trade policies and AI investment.Source 1Source 2 Consumer confidence fell to 89.1 in December from 92.9.Source 5 Job gains expected to accelerate.Source 5

5

Sanofi to Acquire Dynavax Technologies for $2.2 Billion

Dynavax shares surged 38% after Sanofi announced the deal to add hepatitis B and shingles vaccines to its portfolio.Source 3Source 4 Sanofi shares unchanged in premarket.Source 3 Deal highlights biotech M&A in holiday trading.Source 4

6

Novo Nordisk Gets US Approval for Wegovy Pill

Novo Nordisk shares rose 1.8% on FDA approval for oral Wegovy, amid competition from Eli Lilly.Source 4 Shares down 40% YTD despite blockbuster drug success.Source 4 CEO discussed US sales expansion.Source 2

7

Oil Prices Edge Higher on Supply Disruption Fears

US crude added 12 cents to $58.50/barrel, Brent up 8 cents to $61.95, as traders eye Venezuela and Russia risks.Source 1Source 3 Prices monitored amid geopolitical tensions.Source 1 Steady amid holiday caution.Source 3

8

US Holds Off on New Chinese Chip Tariffs

US delays new tariffs on Chinese chips until mid-2027 despite unfair trade accusations.Source 2 Move amid ongoing trade tensions.Source 2 Impacts semiconductor sector outlook.Source 2

9

Japan-US Agree to Expedite $550 Billion Investments

Japan and US to speed up $550bn investment projects under trade deal to lower Trump tariffs.Source 5 First project announcement preparations aligned.Source 5 Boosts bilateral economic ties.Source 5

10

Nomura Holdings Celebrates 100th Anniversary

Nomura marks centennial by establishing Nomura Well-Growing Institute for financial education, social impact, and sustainable investments.Source 7 Aligns with group purpose for AI-era value creation.Source 7 Focuses on learning, connections, and essentials like food, shelter.Source 7

11

Yen Weakness Sparks Intervention Concerns in Japan

Dollar weakened to 156.04 yen amid talk of Japanese intervention; yen rally in Korea noted.Source 2Source 3 Becomes growing concern for Japan.Source 2 Euro eased to $1.1787.Source 3

12

Israel Imposes Special Tax on Banks After Profit Surge

Finance Ministry announced special bank tax following profit increases.Source 5 Amid economic measures post-earthquake impacts deemed temporary by World Bank.Source 5 Targets fiscal adjustments.Source 5